One heart – One Team, the motto for this year’s German Society for Thoracic and Cardiovascular Surgery Congress emphasises that cardiac surgeons and cardiologists must now work more in tandem for their mutual patients. This is not just a short-lived three-day slogan, but a daily reality at the University Heart Centre Hamburg, as EH correspondent Holger Zorn reports
The biggest cause of death for most adult women in industrialised nations is coronary heart disease (CHD). Why the disease affects the genders differently is still not fully understood. European Hospital Editor Brigitte Dinkloh asked Professor Rafaelle Bugiardini MD FESC, from the Department of Internal Medicine Department, University of Bologna, whether he could explain the reasons and what…
A new generation of cardiovascular implantable electronic devices (CIEDs) includes the Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronisation Therapy Defibrillator (CRT-Ds) and Cardiac Resynchronisation Therapy Pacemakers (CRT-Ps). Professor W R Bauer at University Hospital Würzburg has been significantly involved in their development, EH Editor Ralf Mateblowski to ask him about…
Initially limited to the aortic valve, interventions are becoming routine for the mitral valve. Thus the only available product has enjoyed huge commercial success – until now. Report: Holger Zorn
More anatomy details, real-time visualisation of catheter movement, and reduced exposure – MRI has promising potential in rhythmology, explain Professor Matthias Gutberlet and PD Dr Christopher Piorkowski, at the Heart Centre, University Hospital Leipzig, Germany.
Cardiologists are increasingly concerned about patients with persistent hypertension demanding a new technique, in the absence of clinical proof of its long-term benefit. As more related devices are launched, John Brosky reports on the procedure, drawbacks, and a potential €2 billion market.
Michael Rühl from the University of Greifswald, Working Group on Immunoadsorption and Cardiovascular Technology, describes therapies to tackle familial hypercholesterolemia
In a paper published in ”Nature Biotechnology” on the 22nd of July of 2012 Harvard researchers explain how making a jellyfish from rat DNA can help to solve cardiac problems.
So close yet so far away! A fitting description of many diagnostic examinations of heart and lungs. Modern imaging modalities allow these two neighbouring organs to be evaluated together, nevertheless it is rarely done.
Computed tomography (CT) has become central to the diagnosis and characterisation of coronary artery disease (CAD) and, in the future, could even supplant invasive coronary angiography as the technology increases sensitivity.
CVD prevention experts will meet in Dublin from 3-5 May for the leading international forum for preventive cardiology, Finn Snyder reports.
A new transcatheter aortic valve implantation (TAVI) system for transapical treatment of severe aortic stenosis – Acurate TA and delivery system –is a second- generation TAVI device to treat elderly patients. Launched by the Swiss firm Symetis SA, the system gained CE approval last September is on sale in Europe.
Cohort A and B Results. Aortic stenosis is characterised by the hardening and narrowing of the aortic valve that pumps blood into the body’s main artery. It affects nearly 5% of those over 75 in Europe, with an estimated 16,000 Britons suffering from severe aortic stenosis.
Stroke survivors who like art have a significantly higher quality of life than those who do not, according to new research. Patients who appreciated music, painting and theatre recovered better from their stroke than patients who did not.
Every year, around 80,000 lower extremities in Europe have to be (partially) amputated as a result of peripheral arterial occlusive disease (PAOD). Half of the affected patients die within five years of the amputation.
A registry -which includes every patient in Sweden having percutaneous coronary intervention (PCI) for the treatment of acute and stable coronary artery disease- has found that PCI implantations using a new generation of drug-eluting stents is associated with lower rates of relapse (restenosis), stent thrombosis and subsequent mortality than older generation drug-eluting stents and bare-metal…
The German Paediatric Heart Centre (DKHZ) is one of the largest of its kind in Europe. Over 25 years the centre has treated big and small patients with congenital heart defects, very now and then being faced with rare, individual cases that present very particular challenges. In any one year, consultant paediatric cardiologist Professor Martin Schneider MD encounters perhaps five such non-…
With transcatheder aortic valve implants (TAVI) forming some 20% of all heart valve replacement procedures today, and the technology constantly developing, the 'real art' to the intervention's success lies in precise patient selection and procedure performance carried out by a multi-disciplinary and effective team, according to Simon Redwood, Professor of the interventional cardiology at King's…
Italy is a front runner in diabetic foot revascularisation. Among the country’s pioneers is Professor Roberto Gandini, at the Diagnostic Imaging and Interventional Radiology Department, University of Tor Vergata in Rome, who has developed and improved new technical options in peripheral vascular disease intervention, a technique that now saves about 92% of patients from major amputations due…
Prof. Uwe Nixdorff from the European Prevention Centre, Düsseldorf advocates cardiologists combine IMT measurement with ALOKA’s pulse wave intensity function to check for unseen coronary heart disease: “This technique is currently seldom used, however in my experience it provides a more complete picture and enables me to treat patients earlier for life-threatening conditions that are often…
Researchers in Sheffield have been given an mportant grant to trial state-of-the-art computer modelling systems that could provide a breakthrough in the treatment of patients with heart failure.
Schiller reports that its new range of touch screen ECG systems combines precision performance and attractive ergonomics. With a touch to the large, high-resolution colour display, 12-lead ECGs and pulmonary function tests can be recorded, selected and printed in seconds.
From guidelines to daily clinical practice: Cardiac resynchronisation therapy is increasingly important in heart failure treatment. The therapy is complex, the demands to medical technology high. Holger Zorn reports
New research carried out in the UK has revealed that young children with congenital heart disease are at risk of having harmful toxins in their blood, particularly following surgery. Mark Nicholls reports
Devices to treat chronic cardiac disease are winning credibility with new evidence from large-scale patient registries, John Brosky reports
